Dark
Light
System
Institutional Investment Manager
Tekla Capital Management LLC
Tekla Capital Management LLC (CIK: 0001300336) incorporated in Delaware, located at 100 Federal Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q4)
Portfolio Summary: 134 holdings with a total value of $2,757,591,000.
#
Name
Shares
Value ($)
%
Options
Notes
51 Welltower Inc 200,000 12,182,000 0.44% PRN
52 ALERE INC 297,901 11,645,000 0.42%
53 ARDELYX INC COM 639,370 11,585,000 0.42%
54 STRYKER CORP 123,940 11,519,000 0.42%
55 GLAXOSMITHKLINE PLC 285,000 11,500,000 0.42%
56 ZIMMER BIOMET HLDGS INC 102,300 10,495,000 0.38%
57 LTC PPTYS INC COM 236,618 10,208,000 0.37%
58 INTRA-CELLULAR THERAPIES INC 187,800 10,102,000 0.37%
59 SENIOR HOUSING PROPERTIES TRUST 670,504 9,950,000 0.36%
60 ULTRAGENYX PHARMACEUTICAL INC COM 88,400 9,917,000 0.36%
61 IDEXX LAB 132,352 9,651,000 0.35%
62 MEDTRONIC PLC 124,344 9,565,000 0.35%
63 Natera, Inc. 882,358 9,529,000 0.35%
64 SABRA HEALTH CARE REIT INC 456,190 9,229,000 0.33%
65 ICON PLC 114,900 8,928,000 0.32%
66 CEPHEID 10,000,000 8,894,000 0.32% PRN
67 Pieris Pharmaceuticals 3,848,191 8,812,000 0.32%
68 AEGERION PHARMACEUTICALS INC 13,000,000 8,629,000 0.31% PRN
69 UNIVERSAL HLTH SVCS INC 70,300 8,400,000 0.30%
70 COMMUNITY HEALTH SYS INC NEW 304,472 8,078,000 0.29%
71 JUNO THERAPEUTICS INC COM 182,000 8,003,000 0.29%
72 NOVARTIS A G 92,700 7,976,000 0.29%
73 CENTENE CORP DEL 120,000 7,897,000 0.29%
74 LILLY ELI & CO 85,667 7,218,000 0.26%
75 WELLCARE HEALTH PLANS INC 88,652 6,933,000 0.25%
76 CYTOMX THERAPEUTICS INC COM 328,059 6,847,000 0.25%
77 SANOFI SPOND FUNSPONSORED ADR 853,787 6,745,000 0.24%
78 DYNAVAX TECHNOLOGIES CORP 275,000 6,644,000 0.24%
79 KARYOPHARM THERAPEUTICS INC COM 500,324 6,629,000 0.24%
80 CELLECTIS S A 207,250 6,431,000 0.23%
81 RETROPHIN INC 329,949 6,365,000 0.23%
82 AURIS MED HLDG AG 1,268,263 6,202,000 0.22%
83 HERON THERAPEUTICS INC COM 219,000 5,847,000 0.21%
84 FLAMEL TECHNOLOGIES SA SPONSORED ADR 474,288 5,791,000 0.21%
85 EXELIXIS INC 1,023,877 5,775,000 0.21%
86 SAGE THERAPEUTICS INC 97,800 5,702,000 0.21%
87 ACCELERATE DIAGNOSTICS INC 264,625 5,687,000 0.21%
88 ENDOLOGIX INC 551,000 5,455,000 0.20%
89 AKORN INCORPORATED 145,235 5,419,000 0.20%
90 PERRIGO CO PLC 37,300 5,397,000 0.20%
91 SUPERNUS PHARMACEUTICALS INC 2,000,000 5,356,000 0.19% PRN
92 HEALTHCARE RLTY TR 187,224 5,302,000 0.19%
93 FOAMIX PHARMACEUTICALS LTD 652,145 5,289,000 0.19%
94 ALLERGAN PLC 5,000 5,151,000 0.19%
95 TENET HEALTHCARE CORP 164,500 4,984,000 0.18%
96 INOTEK PHARMACEUTICALS CORP 425,000 4,815,000 0.17%
97 MALLINCKRODT PUB LTD CO 61,900 4,620,000 0.17%
98 SAGENT PHARMACEUTICALS INC 286,650 4,561,000 0.17%
99 ARCA BIOPHARMA INCORPORATED COM PAR .001 811,227 3,772,000 0.14%
100 DEPOMED INC 200,000 3,626,000 0.13%
Page 2 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-094941, filed 2016.02.09).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.